[{"Assets_0_Q2_USD":"62870000000.0","CIK":"882095","CommonStockDividendsPerShareDeclared_1_Q2_USD":"0.73","CommonStockDividendsPerShareDeclared_2_Q2_USD":"1.46","CommonStockSharesIssued_0_Q2_shares":"1254000000.0","CommonStockSharesOutstanding_0_Q2_shares":"1254000000.0","Country":"United States","EarningsPerShareBasic_1_Q2_USD":"0.91","EarningsPerShareBasic_2_Q2_USD":"0.93","EarningsPerShareDiluted_1_Q2_USD":"0.91","EarningsPerShareDiluted_2_Q2_USD":"0.92","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"78838305412.0","MinorityInterest_0_Q2_USD":"-21000000.0","NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":"3642000000.0","NetIncomeLoss_1_Q2_USD":"1144000000.0","NetIncomeLoss_2_Q2_USD":"1163000000.0","OfficialName":"Gilead Sciences Inc. Common Stock","PaymentsOfDividends_2_Q2_USD":"1865000000.0","ProfitLoss_1_Q2_USD":"1135000000.0","ProfitLoss_2_Q2_USD":"1147000000.0","RevenuesConverted_1_Q2_USD":"6260000000.0","RevenuesConverted_2_Q2_USD":"12850000000.0","SP500":"SP500","Sector":"Health Care","StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":"20215000000.0","StockholdersEquity_0_Q2_USD":"20236000000.0","Ticker":"GILD","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":"1260000000.0","WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":"1261000000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":"1256000000.0","WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":"1255000000.0","filed":"20220808","footnote":null,"form":"10-Q","fp":"Q2","fy":"2022.0","name":"GILEAD SCIENCES, INC.","period":"20220630","qtrs":"0","uom":"USD"}]